Comparative effect of PPI (proton pump inhibitor) test with rabeprazole, lansoprazole, and omeprazole: Role of endoscopic finding and H.Pylori infection

被引:0
作者
Ichimura, H
Takada, H
Oka, S
Takada, H
Takahashi, M
Kuwayama, H
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A324 / A324
页数:1
相关论文
共 50 条
  • [21] Efficacy of Vonoprazan-based therapy compared to proton pump inhibitor (PPI) in H. pylori eradication therapy
    Ito, Shiori
    Fukami, Yuichi
    Futenma, Tomohisa
    Shin, Takahiro
    Ishii, Ryosuke
    Hara, Hidenori
    Sugiyama, Yuta
    Machida, Tomoyo
    Yonemoto, Yuki
    Ikemiyagi, Hidekazu
    Yoshino, Kohei
    Sakita, Shinya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 254 - 254
  • [22] The influence of H pylori infection on the efficacy of proton pump inhibitor treatment of esophagitis in elderly patients
    Pilotto, A
    Franceschi, M
    Rassu, M
    Bozzola, L
    Soffiati, G
    Valerio, G
    GUT, 2001, 49 : A64 - A65
  • [23] The "second strike" concept of proton pump inhibition:: Closely spaced omeprazole administration in H-pylori infection.
    Pantoflickova, D
    Martinek, J
    Blum, AL
    Cederberg, C
    Stolte, M
    Wiesel, P
    GASTROENTEROLOGY, 1998, 114 (04) : A252 - A252
  • [24] Utilization of H2RA in the era of proton pump inhibitor and H-pylori infection.
    Cheung, R
    Alto, P
    Yella, M
    GASTROENTEROLOGY, 1999, 116 (04) : A51 - A51
  • [25] Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice
    Kaur, Sukhminderjit
    Vaishnavi, Chetana
    Prasad, Kaushal Kishore
    Ray, Pallab
    Kochhar, Rakesh
    MICROBIOLOGY AND IMMUNOLOGY, 2007, 51 (12) : 1209 - 1214
  • [26] Comparative effect of Proton-pump Inhibitors on the Success of Quadruple Therapy for Helicobacter pylori Infection
    Boltin, D.
    Levi, Z.
    Gingold-Belfer, R.
    Schmilovitz-Weiss, H.
    Shochat, T.
    Dickman, R.
    Niv, Y.
    Birkenfeld, S.
    Dotan, I.
    HELICOBACTER, 2019, 24
  • [27] Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
    Murakami, Kazunari
    Okimoto, Tadayoshi
    Kodama, Masaaki
    Sato, Ryugo
    Miyajima, Hajime
    Ono, Masami
    Inoue, Kunimitsu
    Watanabe, Koichiro
    Otsu, Satoshi
    Fujioka, Toshio
    HELICOBACTER, 2006, 11 (05) : 436 - 440
  • [28] Treatment Success With Dual Proton Pump Inhibitor Plus Amoxicillin H. pylori Therapy or PPI, Amoxicillin, Clarithromycin Triple Therapy
    Graham, David Y.
    Javed, Syed U.
    Keihanian, Sara
    Abudayyeh, Suhaib
    Opekun, Antone R.
    GASTROENTEROLOGY, 2010, 138 (05) : S468 - S468
  • [29] Effect of a 7-day therapy with low to high doses of the proton pump inhibitor (PPI) lansoprazole on the intragastric (IG) pH in healthy human subjects
    Harder, H
    Teyssen, S
    Stephan, F
    Pfutzer, R
    Kiel, G
    Singer, MV
    GUT, 1997, 41 : A96 - A96
  • [30] Gastric antral biopsy for histology has a limited role in the detection of Helicobacter pylori in patients on proton pump inhibitor (PPI) therapy.
    Manocha, AP
    Darwish, K
    Aranda-Michel, J
    Bracher, GA
    Weesner, RE
    Martin, SP
    Bleau, BL
    GASTROENTEROLOGY, 1998, 114 (04) : A213 - A213